211 related articles for article (PubMed ID: 36816969)
1. mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma.
Michishita M; Ochiai K; Nakahira R; Azakami D; Machida Y; Nagashima T; Nakagawa T; Ishiwata T
Front Oncol; 2023; 13():1100602. PubMed ID: 36816969
[TBL] [Abstract][Full Text] [Related]
2. Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry.
Michishita M; Saito N; Nozawa S; Furumoto R; Nakagawa T; Sato T; Ochiai K; Azakami D; Katayama K; Nakahira R; Tazaki H; Machida Y; Ishiwata T
J Vet Med Sci; 2019 Sep; 81(9):1238-1248. PubMed ID: 31308293
[TBL] [Abstract][Full Text] [Related]
3. Salinomycin inhibits canine mammary carcinoma
Du H; Zhou B; Zhang H; Jin Y; Zhang D; Lin D
Oncol Lett; 2017 Jul; 14(1):427-432. PubMed ID: 28693187
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells.
Bernard S; Poon AC; Tam PM; Mutsaers AJ
BMC Vet Res; 2021 Dec; 17(1):382. PubMed ID: 34895222
[TBL] [Abstract][Full Text] [Related]
5. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
6. Survival of salivary gland cancer stem cells requires mTOR signaling.
Andrade NP; Warner KA; Zhang Z; Pearson AT; Mantesso A; Guimaraēs DM; Altemani A; Mariano FV; Nunes FD; Nör JE
Cell Death Dis; 2021 Jan; 12(1):108. PubMed ID: 33479203
[TBL] [Abstract][Full Text] [Related]
7. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
[TBL] [Abstract][Full Text] [Related]
8. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
9. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
10. mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
Nakano T; Warner KA; Oklejas AE; Zhang Z; Rodriguez-Ramirez C; Shuman AG; Nör JE
J Dent Res; 2021 Apr; 100(4):377-386. PubMed ID: 33073679
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
12. Isolation of canine mammary cells with stem cell properties and tumour-initiating potential.
Cocola C; Anastasi P; Astigiano S; Piscitelli E; Pelucchi P; Vilardo L; Bertoli G; Beccaglia M; Veronesi MC; Sanzone S; Barbieri O; Reinbold RA; Luvoni GC; Zucchi I
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():214-7. PubMed ID: 19754572
[TBL] [Abstract][Full Text] [Related]
13. An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Alexandre PA; Pires PRL; Saranholi BH; Silva ER; Müller S; Fukumasu H
Sci Rep; 2019 Nov; 9(1):17363. PubMed ID: 31758045
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
15. Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells.
Cataldo D; Aravena G; Escobar A; Tapia JC; Peralta OA; Torres CG
Animals (Basel); 2024 Apr; 14(8):. PubMed ID: 38672378
[TBL] [Abstract][Full Text] [Related]
16. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Serrano C; Guzmán S; Arias JI; Torres CG
BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells.
Karthik GM; Ma R; Lövrot J; Kis LL; Lindh C; Blomquist L; Fredriksson I; Bergh J; Hartman J
Cancer Lett; 2015 Oct; 367(1):76-87. PubMed ID: 26208432
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
19. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
20. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
